These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35938466)

  • 1. Elite and posttreatment controllers, two facets of HIV control.
    Mastrangelo A; Banga R; Perreau M
    Curr Opin HIV AIDS; 2022 Sep; 17(5):325-332. PubMed ID: 35938466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.
    Trémeaux P; Lemoine F; Mélard A; Gousset M; Boufassa F; Orr S; Monceaux V; Gascuel O; Lambotte O; Hocqueloux L; Saez-Cirion A; Rouzioux C; Avettand-Fenoel V
    Microbiol Spectr; 2023 Feb; 11(1):e0326722. PubMed ID: 36692300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies.
    Woldemeskel BA; Kwaa AK; Blankson JN
    EBioMedicine; 2020 Dec; 62():103118. PubMed ID: 33181459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological effector mechanisms in HIV-1 elite controllers.
    Hartana CA; Yu XG
    Curr Opin HIV AIDS; 2021 Sep; 16(5):243-248. PubMed ID: 34270465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Block and lock" viral integration sites in persons with drug-free control of HIV-1 infection.
    Bone B; Lichterfeld M
    Curr Opin HIV AIDS; 2024 May; 19(3):110-115. PubMed ID: 38457193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
    Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
    mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers.
    Lian X; Gao C; Sun X; Jiang C; Einkauf KB; Seiger KW; Chevalier JM; Yuki Y; Martin M; Hoh R; Peluso MJ; Carrington M; Ruiz-Mateos E; Deeks SG; Rosenberg ES; Walker BD; Lichterfeld M; Yu XG
    Sci Transl Med; 2021 Dec; 13(624):eabl4097. PubMed ID: 34910552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.
    Li JZ; Blankson JN
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elite controllers: A heterogeneous group of HIV-infected patients.
    Navarrete-Muñoz MA; Restrepo C; Benito JM; Rallón N
    Virulence; 2020 Dec; 11(1):889-897. PubMed ID: 32698654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
    Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
    J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
    Pernas M; Tarancón-Diez L; Rodríguez-Gallego E; Gómez J; Prado JG; Casado C; Dominguez-Molina B; Olivares I; Coiras M; León A; Rodriguez C; Benito JM; Rallón N; Plana M; Martinez-Madrid O; Dapena M; Iribarren JA; Del Romero J; García F; Alcamí J; Muñoz-Fernández M; Vidal F; Leal M; Lopez-Galindez C; Ruiz-Mateos E
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29212942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elite controllers and lessons learned for HIV-1 cure.
    Lopez-Galindez C; Pernas M; Casado C; Olivares I; Lorenzo-Redondo R
    Curr Opin Virol; 2019 Oct; 38():31-36. PubMed ID: 31252326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elite suppressors have low frequencies of intact HIV-1 proviral DNA.
    Kwaa AK; Garliss CC; Ritter KD; Laird GM; Blankson JN
    AIDS; 2020 Mar; 34(4):641-643. PubMed ID: 31895150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 T-cell regeneration in HIV-1 elite controllers.
    Yang Y; Al-Mozaini M; Buzon MJ; Beamon J; Ferrando-Martinez S; Ruiz-Mateos E; Rosenberg ES; Pereyra F; Yu XG; Lichterfeld M
    AIDS; 2012 Mar; 26(6):701-6. PubMed ID: 22301416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct viral reservoirs in individuals with spontaneous control of HIV-1.
    Jiang C; Lian X; Gao C; Sun X; Einkauf KB; Chevalier JM; Chen SMY; Hua S; Rhee B; Chang K; Blackmer JE; Osborn M; Peluso MJ; Hoh R; Somsouk M; Milush J; Bertagnolli LN; Sweet SE; Varriale JA; Burbelo PD; Chun TW; Laird GM; Serrao E; Engelman AN; Carrington M; Siliciano RF; Siliciano JM; Deeks SG; Walker BD; Lichterfeld M; Yu XG
    Nature; 2020 Sep; 585(7824):261-267. PubMed ID: 32848246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
    de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
    Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control.
    García M; López-Fernández L; Mínguez P; Morón-López S; Restrepo C; Navarrete-Muñoz MA; López-Bernaldo JC; Benguría A; García MI; Cabello A; Fernández-Guerrero M; De la Hera FJ; Estrada V; Barros C; Martínez-Picado J; Górgolas M; Benito JM; Rallón N
    J Mol Med (Berl); 2020 Aug; 98(8):1093-1105. PubMed ID: 32556382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-DNA content in pTfh cells is associated with residual viremia in elite controllers.
    García M; Morcilla V; Navarrete-Muñoz MÁ; Fisher K; Cabello A; López-Bernaldo JC; De La Hera F; Barros C; Fernández-Guerrero M; Estrada V; Górgolas M; Benito JM; Palmer S; Rallón N
    AIDS; 2021 Mar; 35(3):393-398. PubMed ID: 33252487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral, inflammatory, and reservoir characteristics of posttreatment controllers.
    McMahon J; Lewin SR; Rasmussen TA
    Curr Opin HIV AIDS; 2021 Sep; 16(5):249-256. PubMed ID: 34334614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.